T1	Participants 41 154	patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan
T2	Participants 513 582	Nineteen patients with extremity melanoma (n = 16) or sarcoma (n = 3)
T3	Participants 1965 2007	Patients with a measured leak of > or = 1%
T4	Participants 2146 2168	patients without leaks
